NLC Health Ventures has raised €58m since 2023, including €14m this year, to invest in bringing innovations to market that will relieve mounting pressures on healthcare systems globally, it says.
Fund IV has received backing from a range of institutional investors, DFIs and philanthropies. It will invest in rapidly scaling financial services and healthcare businesses in global growth markets in Africa and Asia.
The Belgium-based fund is investing in a dozen companies that aim to achieve systemic changes in environment, skilling & education, and health sectors.
The great majority of healthtech innovations never reach patients due to lack of early-stage funding and business expertise. NLC is changing that by building investible businesses around game-changing healthcare solutions.
Biju Mohandas, global co-head of healthcare investments at LeapFrog Investments, tell us that a “secular shift” in the attitude towards healthcare technology has taken place.
We talk to scientist Susan Greenfield, founder of Neuro-Bio, about her breakthrough discovery in the search for a cure to Alzheimer’s, and the potentially huge social impact of investments in biotech.
UK-based Macmillan Cancer Support’s new fund will invest in startups developing cancer care products and technology. 52North, developer of at-home testing kit for neutropenic sepsis, is the fund’s first investment
BNP Paribas, Bridges Outcomes Partnerships, Rabobank and Oneplanetcrowd back health impact bond to fund a fall prevention programme for the elderly launched last week
From now on you will receive our newsletter 3 times a week (Tue, Thu and Fri).
Free newsletter. Sign up now
Register your email address and receive our newsletter direct to your inbox.
Offering independent news and analysis about impact investing and sustainable finance.
For free.
